{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$5.86 vs. cons $5.79",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "BEAT",
      "answer": "pred ~$1.59bn vs. cons $1.57bn",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~22.8% vs. cons 22.6%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "3Q26 adjusted diluted EPS outlook",
      "prediction": "LOWER",
      "answer": "guide ~$5.95 vs. cons $6.03 (3Q26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted diluted EPS outlook",
      "prediction": "LOWER",
      "answer": "guide ~$24.00 vs. cons $24.15 (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -0.8,
  "day5_path": "FADE",
  "day5_rationale": "A modest 2Q adjusted-EPS beat of ~$5.86 versus ~$5.79 is likely initially positive, but a ~$5.95 3Q outlook versus ~$6.03 consensus and ~$24.00 FY26 midpoint versus ~$24.15 consensus imply out-period estimate pressure.",
  "day5_confidence": "MEDIUM"
}